Mark G. Kris, MD, discusses 1 of the major topics of discussion from the 15th Annual New York Lung Cancers Symposium, among other areas of focus at the meeting.
Mark G. Kris, MD, medical oncologist, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses 1 of the major topics of discussion from the 15th Annual New York Lung Cancers Symposium, among other areas of focus at the meeting.
One of the key messages at this year’s meeting is that coronavirus disease 2019 (COVID-19) is now another complication of lung cancer, says Kris. The discussions during this meeting will focus on some very important issues in lung cancer, and at this time, COVID-19 has become a threat for patients with lung cancer that needs to be addressed.
Kris says that all but 2 of his patients with lung cancer died from the cancer as opposed to COVID-19, so this demonstrates it is a threat to patients that needs to be managed. This is an important topic at this year’s meeting, among others that will address new therapeutic approaches and emerging technologies in the lung cancer space.